Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Clinical trial NCT01182675 · TERMINATED

Trial details

NCT number: NCT01182675
Sponsor: University of California, San Francisco
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Combined Immunodeficiency

Start date: 2010-08-01
Primary completion: 2013-09-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.